Therapeutic potential of essential oils in Acanthamoeba keratitis

被引:2
|
作者
Porto, Douglas Santos [1 ]
Caumo, Karin Silva [1 ]
Caon, Thiago [1 ]
机构
[1] Univ Fed Santa Catarina, Pharm Postgrad Program PGFar, BR-88040900 Florianopolis, SC, Brazil
关键词
Acanthamoeba keratitis; Essential oils; Cytotoxicity; Anti-inflammatory action; THYMUS-CAPITATUS HOFF; CLOVE SYZYGIUM-AROMATICUM; PUSILLA BROT. BREISTR; CHEMICAL-COMPOSITION; PIPER-HISPIDINERVUM; AMEBICIDAL ACTIVITY; ANTI-ACANTHAMOEBA; IN-VITRO; MATRIX METALLOPROTEINASES; ANTIMICROBIAL ACTIVITY;
D O I
10.1007/s11101-022-09850-z
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
New therapeutic agents for amoebic keratitis are needed considering that drugs currently marketed are toxic and not effective against protozoan cystic forms. The antimicrobial action of essential oils (EOs) is already reported in the literature, which has motivated investigations of their anti-Acanthamoeba potential. Unlike synthetic drugs, plant materials have been often identified as less cytotoxic. In this review, the anti-Acanthamoeba potential of EOs was demonstrated not only based on the anti-protozoan activity as anti-inflammatory activity. Finally, in vitro cytotoxicity studies of EOs active were analyzed. EOs were able to prevent the conversion of the protozoan trophozoite to cystic form. In a study performed with Trachyspermum ammi EO, 100% of Acanthamoeba cysts were eliminated. Thymus capitatus and Limonium oleifolium EOs showed to be more active against Acanthamoeba, presenting IC50 values close to chlorhexidine and lower than amphotericin B. For these two OEs, low in vitro cytotoxicity was also found, which result in a high selectivity index (SI > 10). Therefore, safer and more effective therapies could be achieved with OEs, and in vivo assays should be urgently performed to confirm these benefits.
引用
收藏
页码:543 / 563
页数:21
相关论文
共 50 条
  • [21] Acanthamoeba keratitis
    Bouheraoua, N.
    Labbe, A.
    Chaumeil, C.
    Liang, Q.
    Laroche, L.
    Borderie, V.
    JOURNAL FRANCAIS D OPHTALMOLOGIE, 2014, 37 (08): : 640 - 652
  • [22] ACANTHAMOEBA AND KERATITIS
    SCAT, Y
    BATELLIER, L
    CHAUMEIL, C
    MEDECINE ET MALADIES INFECTIEUSES, 1995, 25 (05): : 721 - 726
  • [23] Acanthamoeba Keratitis
    Meltendorf, C.
    Duncker, G.
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2011, 228 (03) : R29 - R41
  • [24] ACANTHAMOEBA KERATITIS
    不详
    LANCET, 1988, 1 (8587): : 687 - 688
  • [25] ACANTHAMOEBA KERATITIS
    HAY, J
    SEAL, DV
    KIRKNESS, CM
    JOURNAL OF CLINICAL PATHOLOGY, 1993, 46 (04) : 382 - 382
  • [26] Therapeutic Potential of Essential Oils Against Ulcerative Colitis: A Review
    Li, Jinkai
    Zhang, Xiaofei
    Luan, Fei
    Duan, Jiawei
    Zou, Junbo
    Sun, Jing
    Shi, Yajun
    Guo, Dongyan
    Wang, Changli
    Wang, Xiao
    JOURNAL OF INFLAMMATION RESEARCH, 2024, 17 : 3527 - 3549
  • [27] ACANTHAMOEBA KERATITIS
    MASKE, R
    HILL, JC
    BOWEN, RM
    LASTOVICA, AJ
    SOUTH AFRICAN MEDICAL JOURNAL, 1989, 76 (09): : 516 - 516
  • [28] ACANTHAMOEBA KERATITIS
    YEOH, R
    WARHURST, DC
    FALCON, MG
    BRITISH JOURNAL OF OPHTHALMOLOGY, 1987, 71 (07) : 500 - 503
  • [29] Acanthamoeba keratitis
    Seal, DV
    Beattie, TK
    Tomlinson, A
    Fan, D
    Wong, E
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2003, 87 (04) : 516 - 517
  • [30] Acanthamoeba keratitis
    Szentmary, N.
    Daas, L.
    Matoula, P.
    Goebels, S.
    Seitz, B.
    OPHTHALMOLOGE, 2013, 110 (12): : 1203 - 1210